Physiological and histological effects of apigenin and luteolin on Cytarabine injected rats

Physiological and histological effects of apigenin and luteolin on Cytarabine injected rats

The present study was undertaken to study the effect of apigenin and luteolin on physiological and histological changes in rats treated with cytarabine drugs. Thirty-five albino healthy male adult rats with equal age weighing 250 -300g were enrolled. Rats were randomly divided into seven g...

Full description

Bibliographic Details
Main Authors:	Ghada A. Taqa, Omar N. Sultan
Format:	Article
Language:	Arabic
Published:	College of Science for Women, University of Baghdad 2024-01-01
Series:	Baghdad Science Journal
Subjects:	Apigenin, Cholesterol, Cytarabine, Liver enzymes, Luteolin
Online Access:	https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/7000

Similar Items

Virtual Screening of Apigenin and Luteolin as Natural Aromatase Inhibitors for the Treatment of Breast Cancer Patients
by: Baydaa Hamad Obaid Saleh
Published: (2024-10-01)

Identification of Apigenin and Luteolin in Artemisia annua L. for the Quality Control
by: Rattana Phadungrakwittaya, et al.
Published: (2019-05-01)

Identification of Apigenin and Luteolin in Artemisia annua L. for the Quality Control
by: Rattana Phadungrakwittaya, et al.
Published: (2019-05-01)

Determination of Luteolin and Apigenin in Herbal Teas by Online In-Tube Solid-Phase Microextraction Coupled with LC–MS/MS
by: Atsushi Ishizaki, et al.
Published: (2024-05-01)

Interaction of Lipophilic Cytarabine Derivatives with Biomembrane Model at the Air/Water Interface
by: Jhon Fernando Berrio Escobar, et al.
Published: (2022-09-01)

Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells
by: Lingchao Miao, et al.
Published: (2023-11-01)

Intake of oligoelements with cytarabine or etoposide alters dopamine levels and oxidative damage in rat brain
by: David Calderón Guzmán, et al.
Published: (2024-05-01)

Modulation of Human Sperm Mitochondrial Respiration Efficiency by Plant Polyphenols
by: Alessandra Ferramosca, et al.
Published: (2021-02-01)

Recent insights into luteolin and its biological and pharmacological activities
by: Priscilla Nadalin, et al.
Published: (2024-05-01)

Protective and therapeutic effects of apigenin on thioacetamide-induced hepatotoxicity in male rats: physiological and morphological study
by: Zaenah Zuhair Alamri
Published: (2024-03-01)

Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia
by: Abdelrahman R. Said, et al.
Published: (2024-11-01)

Synthesis and Antioxidant Activity of Selenized Apigenin
by: Yawen GAO, et al.
Published: (2025-02-01)

UHPLC-UV/PDA Method Validation for Simultaneous Quantification of Luteolin and Apigenin Derivatives from <i>Elaeis guineensis</i> Leaf Extracts: An Application for Antioxidant Herbal Preparation
by: Mohamad Shazeli Che Zain, et al.
Published: (2021-02-01)

Comparative Study of Antiviral Activity of Luteolin and 7,3’-Disulfate Luteolin
by: N. V. Krylova, et al.
Published: (2020-05-01)

Standard dose Cytarabine-Induced Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Report
by: Mehrshad Ebrahimpour, et al.
Published: (2024-10-01)

Advanced Photocatalytic Degradation of Cytarabine from Pharmaceutical Wastewaters
by: Alexandra Berbentea, et al.
Published: (2024-05-01)

Flavonoids Modulate <i>Aspergillus flavus</i> Proliferation and Aflatoxin Production
by: Lina Castano-Duque, et al.
Published: (2022-11-01)

Cytarabine Induced Reproductive Histopathological Changes in Albino Male Mice
by: Niran A. Ibrahim, et al.
Published: (2017-01-01)

Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience
by: Pravdić Zlatko, et al.
Published: (2024-01-01)

Apigenin as an emerging hepatoprotective agent: current status and future perspectives
by: Cheng Wang, et al.
Published: (2024-12-01)

Whole-cell biosynthesis of cytarabine by an unnecessary protein-reduced Escherichia coli that coexpresses purine and uracil phosphorylase
by: Li, Ping, et al.
Published: (2022)

Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine
by: Lais Moreira Lopes, et al.
Published: (2024-10-01)

The First Evidence of Gibberellic Acid’s Ability to Modulate Target Species’ Sensitivity to Honeysuckle (<i>Lonicera maackii</i>) Allelochemicals
by: Csengele Éva Barta, et al.
Published: (2023-02-01)

Apigenin attenuates serum concentrations of TNF-a, interleukin 1b and interleukin 6 in lipopolysaccharide-stimulated rats
by: Mohammad Sofiabadi
Published: (2024-07-01)

Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy
by: Sachin Dhiman, et al.
Published: (2024-11-01)

AHR signaling pathway mediates mitochondrial oxidative phosphorylation which leads to cytarabine resistance
by: Jia Yan, et al.
Published: (2024-02-01)

Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin
by: Peng, Minhua, et al.
Published: (2017)

Revisiting luteolin: An updated review on its anticancer potential
by: Abdur Rauf, et al.
Published: (2024-03-01)

Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone
by: Wenqian Wang, et al.
Published: (2024-01-01)

Effects of <i>Tithonia diversifolia</i> Extract as a Feed Additive on Digestibility and Performance of Hair Lambs
by: Olga Teresa Barreto-Cruz, et al.
Published: (2024-12-01)

Investigating the Impact of Flavonoids on <i>Aspergillus flavus</i>: Insights into Cell Wall Damage and Biofilms
by: Lina Castano-Duque, et al.
Published: (2024-09-01)

Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study
by: Maryam Melaibari, et al.
Published: (2023-05-01)

Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis
by: Yang Qiu, et al.
Published: (2024-04-01)

Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies
by: Chunxia Zhu, et al.
Published: (2024-09-01)

Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma
by: Deepti Singh, et al.
Published: (2024-05-01)

Research progress on antisepsis effect of apigenin and its mechanism of action
by: Lin Zhu, et al.
Published: (2023-11-01)

A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
by: Kai Zhao, et al.
Published: (2024-04-01)

Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles
by: Imran Kazmi, et al.
Published: (2022-04-01)

Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma
by: Zhijuan Zhu, et al.
Published: (2024-07-01)

Two chromatographic methods for determination of cytarabine and dexamethazone; two co-administered drugs for the treatment of leukemia: green analytical perspective
by: Maimana A. Magdy, et al.
Published: (2024-05-01)